Diabetes devices can significantly improve glycemic management and are the standard of care for people with type 1 diabetes (T1D), but the technology also creates a unique set of stresses and burdens that, if not addressed, limit their effectiveness and may cause patients to stop using them.

Over half (56%) of people with T1D who use continuous glucose monitors (CGMs), insulin pumps, automated insulin delivery (AID) systems, or other technology experience moderate-to-extreme emotional and mental burden associated with their devices, according to survey results presented during a special interest group session about “diabetes device distress” at the American Diabetes Association (ADA) 85th Scientific Sessions in Chicago.

The stresses include worry that the device might fail, distress ov

See Full Page